Mode
Text Size
Log in / Sign up

Digital self-management technologies show small-to-moderate benefit for medication adherence in chronic diseaseCan apps and texts help people stick to their medications? A review finds modest benefits

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider digital self-management tools for adherence support, but effects are modest and vary by context.

A systematic review and meta-analysis pooled data from 52 studies involving adults with various chronic diseases to assess the effectiveness of digital self-management technologies—including mobile health apps, SMS reminders, and web-based platforms—on medication adherence. The comparator was standard care or other control groups, though specifics were not reported. The pooled random-effects analysis showed a statistically significant, small-to-moderate benefit, with an effect size of Cohen's d = 0.268 (95% CI 0.123-0.414, p = 0.0003). Effects were largest for medium-duration interventions (d = 0.50) and varied markedly by country, ranging from d = 2.29 in Iran to d = -0.94 in Taiwan. A trim-and-fill adjustment for potential publication bias increased the pooled effect to d = 0.366.

Safety and tolerability data were not reported across the included studies. The analysis has important limitations, including high statistical heterogeneity (I² = 89%), which suggests substantial variation in true effects across studies, and possible publication bias as indicated by Begg's test. The evidence base included RCTs, quasi-experimental, and controlled before-after studies, establishing an association but not definitive causality.

For practice, this meta-analysis indicates that digital self-management tools can be associated with improved medication adherence in chronic disease populations, but the effect is modest and highly context-dependent. The significant variation by geography and intervention characteristics underscores that these technologies are not uniformly effective. Clinicians should consider local evidence and patient preferences when recommending specific digital tools, recognizing that the overall evidence strength is tempered by heterogeneity and potential bias.

Sticking to a daily medication routine is tough, especially when you're managing a chronic condition for the long haul. A major review of 52 studies asked whether digital helpers—like smartphone apps, text message reminders, and web platforms—could make that daily task easier for adults with chronic diseases. The analysis found these technologies do provide a statistically significant, though modest, benefit in helping people take their medications as prescribed. The overall effect was small-to-moderate, but the story gets more interesting when you look closer. The benefit wasn't consistent everywhere; it varied dramatically from country to country, and medium-duration programs seemed to work best. The researchers also noted a high level of variation among the studies they analyzed, which makes it hard to pin down one clear answer. They also found signs that studies with positive results might be more likely to get published, which could mean the true benefit is slightly higher than their main calculation showed. So, while this review suggests digital nudges can help, it also highlights that their effectiveness depends heavily on the specific context—what works in one place or for one group might not work as well elsewhere.

What this means for you:
Digital reminders offer modest help with medication routines, but their effectiveness depends heavily on context.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Chronic diseases require sustained medication adherence, yet nonadherence remains common, leading to poor outcomes and increased healthcare costs. Digital self-management technologies such as mobile health (mHealth) apps, SMS reminders, and web-based platforms offer scalable ways to support adherence, but evidence on their overall effectiveness across diverse contexts is fragmented. AIM: To systematically review and meta-analyze the effectiveness of self-management technologies in improving medication adherence among adults with chronic diseases and to examine potential moderators of intervention impact. METHODS: Following PRISMA guidelines, we searched PubMed, Scopus, Web of Science, CINAHL, and JMIR for peer-reviewed studies (January 2010-June 2025) evaluating digital self-management interventions with adherence outcomes and comparator groups. Eligible designs included RCTs, quasi-experimental, and controlled before-after studies in adults with chronic disease. Random-effects meta-analysis estimated pooled effect sizes (Cohen's d). Heterogeneity (I), subgroup analyses, and publication bias (Egger's, Begg's, trim-and-fill) were assessed. RESULTS: Fifty-two studies were included, spanning 2015-2025. Early interventions (2015-2019) focused on feasibility, using SMS and basic web tools; later years (2021-2025) showed technological maturity, dominated by mHealth apps integrating monitoring, reminders, and education. The pooled random-effects effect size was d = 0.268 (95% CI 0.123-0.414, p = 0.0003), indicating a small-to-moderate benefit. Heterogeneity was high (I = 89%). Medium-duration (10.8-24 weeks) interventions had the largest effect (d = 0.50), and effects varied markedly by country (e.g., Iran d = 2.29; Taiwan d = -0.94). Begg's test suggested possible publication bias; trim-and-fill adjustment increased the pooled effect to d = 0.366. LINKING EVIDENCE TO ACTION: Digital self-management technologies yield a statistically significant, small-to-moderate improvement in medication adherence across chronic diseases, with potential underestimation due to selective reporting. Effectiveness is moderated by temporal trends, geography, intervention duration, and study design, underscoring the need for context-specific adaptation and methodological rigor. Future research should prioritize large, well-controlled trials, pre-registration, and exploration of cultural and systemic determinants to optimize intervention impact.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.